SRPT news · SRPT stock

Moderna Stock Carries A Market Value Its Revenue Does Not Support

Yahoo Finance · Aug 26, 2026 · Sarepta Therapeutics Inc (SRPT)

Moderna's commercial business has shrunk and is lossmaking, which puts the weight of its market value on a pipeline rather than on revenue.

Original at Yahoo Finance

Not investment advice. Cached headline, not a full reprint.